These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796 [No Abstract] [Full Text] [Related]
3. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study. Guan B; Huang X; Xia H; Guan G; Xu B Front Oncol; 2022; 12():941786. PubMed ID: 36263216 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study. Wang P; Wang Z; Liu Y; Xie J; Ren Y Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969 [TBL] [Abstract][Full Text] [Related]
5. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408 [TBL] [Abstract][Full Text] [Related]
6. Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed. Bilgetekin I; Basal FB J Coll Physicians Surg Pak; 2020 Sep; 30(9):933-939. PubMed ID: 33036677 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197 [TBL] [Abstract][Full Text] [Related]
8. Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer. Yang G; Liu P; Zheng L; Zeng J Front Surg; 2022; 9():1004687. PubMed ID: 36406359 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Wang Y; Chen L; Zhang B; Song W; Zhou G; Xie L; Yu D Front Oncol; 2021; 11():639909. PubMed ID: 33816284 [TBL] [Abstract][Full Text] [Related]
10. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer. Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318 [TBL] [Abstract][Full Text] [Related]
11. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Ding Y; Liu Z; Li J; Niu W; Li C; Yu B BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180 [TBL] [Abstract][Full Text] [Related]
12. The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients. Wang H; Huang Z; Xu B; Zhang J; He P; Gao F; Zhang R; Huang X; Shan M Clin Transl Oncol; 2024 Jun; 26(6):1467-1479. PubMed ID: 38190034 [TBL] [Abstract][Full Text] [Related]
13. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma. Sun Y; Huang Z; Chi P Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604 [TBL] [Abstract][Full Text] [Related]
15. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer. Mehraj A; Baba AA; Khan B; Khan MA; Wani RA; Parray FQ; Chowdri NA J Cancer Res Ther; 2022 Dec; 18(Supplement):S391-S396. PubMed ID: 36510993 [TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer. Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S Oncology; 2023; 101(6):349-357. PubMed ID: 36273439 [TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. Tong YS; Tan J; Zhou XL; Song YQ; Song YJ J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030 [TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation-based predictors of pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. Xu N; Li W; Huang F; Yang J; Wen Z; Yin L; Zhang Y; Zhao J; Zhou R; Yang J J Cancer Res Ther; 2022 Apr; 18(2):438-444. PubMed ID: 35645112 [TBL] [Abstract][Full Text] [Related]
19. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843 [TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease. Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J Front Immunol; 2021; 12():691364. PubMed ID: 34248983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]